Search Result "V-Life MDS."


Implication of microRNAs in the Pathogenesis of MDS

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3170-3179
Author(s): Jing Fang,Melinda Varney,Daniel T. Starczynowski

Update on MDS Therapy: From Famine to Feast

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2010 Page: 187-198
Author(s): Preeti Chaudhary, Chirag Shah

Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2323-2332
Author(s): Anna Mies, Ekaterina Bulycheva, Inga Mandac Rogulj, Lorenz C. Hofbauer, Uwe- Platzbecker

DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 315-321
Author(s): Claudia I. Muller, Bjorn Ruter, H. Phillip Koeffler, Michael Lubbert

Endotoxin Recognition Molecules MD-2 and Toll-like Receptor 4 as Potential Targets for Therapeutic Intervention of Endotoxin Shock

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3 Issue: 3 Year: 2004 Page: 291-297
Author(s): Kensuke Miyake

Clinical Trial

An 18F-MD-PSMA (Multi-dentate PMSA Imaging Agent) PET/CT in ProstateCancer Relapse: Results of a Retrospective Trial

Journal: Current Radiopharmaceuticals
Volume: 17 Issue: 4 Year: 2024 Page: 382-397
Author(s):

Research Article

Design, Synthesis, and Pharmacological Evaluation of SubstitutedOxadiazole-Pyridazin-3-One Derivatives as Antioxidant andAntimicrobial Agents

Journal: Anti-Infective Agents
Volume: 20 Issue: 4 Year: 2022 Page: 36-45
Author(s): Dinesh K. Mehta

Insight into the Binding Mode between HIV-1 Integrase and Pyrimidone Analogue Inhibitors with MD Simulation and 3D-QSAR

Journal: Medicinal Chemistry
Volume: 9 Issue: 3 Year: 2013 Page: 420-433
Author(s): Songyao Ma,Wei Ye,Dingjue Ji,Hai-Feng Chen

Research Article

Anti-cancer Effects of Curcumin on Myelodysplastic Syndrome through the Inhibition of Enhancer of Zeste Homolog-2 (EZH2)

Journal: Current Cancer Drug Targets
Volume: 19 Issue: 9 Year: 2019 Page: 729-741
Author(s): Ling Ma,Xia Zhang,Zhiqiong Wang,Lifang Huang,Fankai Meng,Lihua Hu,Yan Chen,Jia Wei

How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5362-5373
Author(s): Thomas Cluzeau, Guillaume Robert, Arnaud Jacquel, Patrick Auberger

Previous   Next

Go To   Results 1 - 1 of 7679

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy